Project Grant HT94252510785
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
This federal Project Grant award of $563,707.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the University of Queensland in Australia to predict early-stage melanoma at high risk of recurrence through multiomics profiling. The grant, awarded on September 1, 2025, aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. The University of Queensland, a...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $506,785.00 to The University of Queensland to conduct research on "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling." The award period runs from September 1, 2025, to August 31, 2028. This research aims to develop innovative approaches for early detection and risk assessment of melanoma, a critical medical...
The Defense Health Agency awarded a $744,997 Project Grant to the University of Queensland in Australia under the Military Medical Research and Development program (CFDA 12.420). This grant, titled "DISCOVERING THERAPEUTIC VULNERABILITIES OF CIRCULATING MELANOMA CLUSTERS," provides funding for the university to conduct cutting-edge biomedical research on melanoma from June 1, 2024 through May 31, 2027. The University of Queensland, a leading research institution in Australia, has an...
The University of Queensland in Australia was awarded a $1,488,596 Project Grant from the Department of the Army Medical Command to support melanoma research from September 2022 through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues. Under this award, The University of Queensland...
The University of Queensland in Australia was awarded a $744,744 USD project grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "Understanding the Role of Immature Myeloid Cells in Early Melanoma Establishment" from September 30, 2022 to September 29, 2025. Through this funding, researchers at The University of Queensland will investigate the role of immature myeloid...
The University of Queensland in Australia was awarded a $2,383,881 Project Grant from the Department of the Army Medical Command on September 15, 2022 to complete work by September 14, 2026. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative and impactful research, as well as investigate medical solutions for the...
The Department of Defense's Defense Health Agency awarded a $1,205,784 Project Grant to Queensland University of Technology (QUT) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "ACCELERATING TRANSLATION OF A NOVEL METAP2 INHIBITOR IN TREATMENT-RESISTANT AND AGGRESSIVE-VARIANT PROSTATE CANCER," runs from July 1, 2024 to June 30, 2027. The project aims to accelerate the translation of a novel MetAP2 inhibitor therapy for treating...
This $1,214,449 federal Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund the development and translation of a multimodal therapeutic agent and medical countermeasure for the treatment of military-related toxic exposures. The awardee, Queensland University of Technology (QUT) in Australia, will lead this 3-year research effort from September 1, 2024 to August 31, 2027. QUT is a prominent...
The University of Queensland in Australia was awarded a $520,011 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from August 1, 2022 to July 31, 2025 on a novel mediator of cholangiocarcinoma that has potential as a diagnostic and treatment target. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
This federal Project Grant award in the amount of $733,068.00 was issued by the Defense Health Agency to the University of Melbourne on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project titled "Investigating Transcript Diversity as a Driver of Melanoma Progression and Recurrence." The University of Melbourne will conduct basic, translational, and clinical research aimed at developing new...